Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Engineered Bacteria Designed to Detect Gut Inflammation

A bioengineering team at Rice University developed a genetically modified form of bacteria that in lab mice detects inflammatory diseases in the gut. . . . → Read More: Engineered Bacteria Designed to Detect Gut Inflammation

Antibody Shows Promise Against Marburg Virus Infections

Tests with lab animals show an experimental synthetic antibody protects against deadly Marburg and Ravn viruses as long as 5 days following infections. . . . → Read More: Antibody Shows Promise Against Marburg Virus Infections

FDA Shown Approving New Drugs Faster than Europe

An analysis of regulatory actions in the U.S. and Europe, shows the U.S. Food and Drug Administration approves more new therapies and faster than the European Medicines Agency. . . . → Read More: FDA Shown Approving New Drugs Faster than Europe

Umbilical Cord Blood Evaluated for Autism Treatment

Results from a clinical trial show infusions of a child’s own umbilical cord blood are safe for treating autism spectrum disorder, and provide initial signs of effectiveness. . . . → Read More: Umbilical Cord Blood Evaluated for Autism Treatment

Artificial Pancreas Shown Feasible for Young Children

An integrated system combining a glucose monitor and insulin pump to simulate the human pancreas is shown to be feasible for young children with type 1 diabetes. . . . → Read More: Artificial Pancreas Shown Feasible for Young Children

Triple-Drug Inhaler Shown to Cut COPD Attacks

Results from a year-long clinical trial show that an inhaler with three types of drugs reduces the number of COPD attacks compared to a common single-drug inhaler. . . . → Read More: Triple-Drug Inhaler Shown to Cut COPD Attacks

Zika DNA Vaccine Begins Clinical Trial

A new clinical trial is underway testing a Zika vaccine that uses genetically-engineered DNA to generate an immune response against the disease. . . . → Read More: Zika DNA Vaccine Begins Clinical Trial

Start-Up Licensing Flexible Genome-Editing Technology

A start-up biotechnology company is licensing techniques from two universities that make genome editing more flexible and better control gene expression. . . . → Read More: Start-Up Licensing Flexible Genome-Editing Technology

NIH Funds Seen Boosting Industry Patents

An analysis of grants issued by National Institutes of Health shows a large percentage of those grants, directly or indirectly, result in patented technologies in industry. . . . → Read More: NIH Funds Seen Boosting Industry Patents

Univ. Spin-Off Designing Heart Disease Screening App

A spin-off enterprise from Massachusetts Institute of Technology is creating a system using a smartphone camera to detect heart rhythm problems that lead to a stroke. . . . → Read More: Univ. Spin-Off Designing Heart Disease Screening App